Robert Horsburgh
Profiles

Charles R Horsburgh, Jr, MD

Professor, Global Health - Boston University School of Public Health

(617) 358-3758
rhorsbu@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Other Positions

  • Professor, Epidemiology - Boston University School of Public Health
  • Professor, Biostatistics - Boston University School of Public Health
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • Case Western Reserve University, MD Field of Study: Medicine
  • Yale University, MS Field of Study: Urban Studies
  • Princeton University, AB Field of Study: Architecture

Websites

Classes Taught

  • SPHEP730
  • SPHEP764
  • SPHEP784
  • SPHEP911
  • SPHGH941

Publications

  • Published on 2/11/2026

    Campbell JI, Brooks MB, Dankovchik J, Giebultowicz S, Falkenstein A, Angier H, Horsburgh CR, Tschampl CA, Haberer JE, Bressler J, Epstein RL, Jenkins HE, Jacobson K. Uncovering household tuberculosis infection testing and care patterns using a novel bioinformatics linkage strategy. Clin Infect Dis. 2026 Feb 11. PMID: 41668263.

     Read At: PubMed
  • Published on 2/4/2026

    Sinha P, Bhargava M, Dauphinais MR, Carwile ME, Horsburgh CR, Singh UB, Sarkar S, Bhargava A, Menzies NA. In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study. Clin Infect Dis. 2026 Feb 04; 81(6):1126-1134. PMID: 40833109.

     Read At: PubMed
  • Published on 2/4/2026

    Swartwood NA, Cohen T, Marks SM, Hill AN, Beeler Asay GR, Self J, Feng PI, Horsburgh CR, Salomon JA, Menzies NA. Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: A Bayesian Analysis. Clin Infect Dis. 2026 Feb 04; 81(6):e659-e667. PMID: 40036593.

     Read At: PubMed
  • Published on 2/1/2026

    Regan M, Cui H, Swartwood NA, Li Y, Marks SM, Barham T, Khan A, Winston CA, Cohen T, Horsburgh CR, Salomon JA, Menzies NA. The potential effect of a geographically focused intervention against tuberculosis in the USA: a simulation modelling study. Lancet Public Health. 2026 Feb; 11(2):e82-e91. PMID: 41611367.

     Read At: PubMed
  • Published on 1/1/2026

    Martinez L, Campbell JI, Linde L, Boulahbal F, Cayla JA, Chakhaia T, Chan PC, Chen C, Fang CT, Fox G, Grandjean L, Hannoun D, Hesseling A, Horsburgh CR, Huang LM, Liu Q, Mazahir R, Lee CH, Lee LN, Bennet R, Nejat S, Gupta A, Das M, Murray M, Huang CC, Del Corral H, Benjumea-Bedoya D, Shen Y, Becerra M, Chang V, Krishnan S, Heinmueller P, Brewer T, Isaakidis P, Hauri AM, Shah L, Trieu L, Seddon JA. The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis. Am J Respir Crit Care Med. 2026 Jan 01; 212(1):129-137. PMID: 40986702.

     Read At: PubMed
  • Published on 12/5/2025

    Shapiro AN, Mohammed S, Horsburgh CR, Jenkins HE, White LF. Adapting Back-calculation Methods to Estimate the Incidence of Tuberculosis. Epidemiology. 2026 Mar 01; 37(2):220-227. PMID: 41481913.

     Read At: PubMed
  • Published on 12/1/2025

    Phillips PPJ, Peloquin CA, Sterling TR, Mitnick CD, Horsburgh CR. Reply to Liao et al.: Optimizing Levofloxacin Dosing for Multidrug-resistant Tuberculosis in Low-Fat-Free Mass Asian Populations. Am J Respir Crit Care Med. 2025 Dec; 211(12):2422-2423. PMID: 40737625.

     Read At: PubMed
  • Published on 10/6/2025

    Rosen LV, Thielking AM, Dugdale CM, Montepiedra G, Kalk E, Kim S, LaCourse SM, Mathad JS, Freedberg KA, Horsburgh CR, Paltiel AD, Wood R, Ciaranello AL, Reddy KP. Tuberculosis Preventive Treatment for Pregnant People With HIV in South Africa: A Modeling Analysis of Clinical Benefits and Risks. Clin Infect Dis. 2025 Oct 06; 81(3):613-622. PMID: 39544107.

     Read At: PubMed
  • Published on 9/22/2025

    Carwile ME, Prakash Babu S, Cintron C, Dauphinais M, Pan SJ, Thulasingam M, Horsburgh CR, Sarkar S, Hochberg NS, Sabin LL, Flynn D, Kumar B, Sinha P, Singh UB. TB stigma in India: A narrative review of types of stigma, gender differences, and potential interventions. PLOS Glob Public Health. 2025; 5(9):e0005109. PMID: 40982550.

     Read At: PubMed
  • Published on 9/10/2025

    Sinha P, Karoly M, Padmapriyadarsini C, Paradkar M, Mave V, Gupte N, Gupta A, Dauphinais M, Babu SP, Gaikwad S, Cox SR, Golub J, Cintron C, Thangakunam B, Ezhumalai K, Ponnuraja C, Tornheim JA, Christopher DJ, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR, Shivakumar SVBY, Salgame P, Bollinger RC, Sarkar S, Gupte AN. Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort Analysis. Chest. 2026 Jan; 169(1):64-72. PMID: 40939932.

     Read At: PubMed

View 374 more publications:View Full Profile at BUMC

News & In the Media

View all profiles